Insmed Incorporated (INSM) earnings: date, estimates, results and stock reactions
Over the last 12 reports the stock moved 9.8% on average (either way), rising 5 times and falling 7. EPS beat estimates 3 of 12 times; revenue 11 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-29 | -0.46 | -0.38 | -20.2% | 524.4M | 500.4M | +16.1% |
| Q2 FY2026 | 2026-08-06 | -0.06 | -0.67 | +91.1% | 425.5M | 395.5M | +32.4% |
| Q1 FY2026 | 2026-05-07 | -0.76 | -0.96 | +21.1% | 306.0M | 300.8M | -26.1% |
| Q4 FY2025 | 2026-02-19 | -1.54 | -1.07 | -43.9% | 263.8M | 231.2M | +9.1% |
| Q3 FY2025 | 2025-10-30 | -1.75 | -1.33 | -31.6% | 142.3M | 115.4M | +13.6% |
| Q2 FY2025 | 2025-08-07 | -1.70 | -1.30 | -30.8% | 107.4M | 104.1M | -1.5% |
| Q1 FY2025 | 2025-05-08 | -1.42 | -1.34 | -6.0% | 92.8M | 91.5M | -4.7% |
| Q4 FY2024 | 2025-02-20 | -1.32 | -1.17 | -12.8% | 104.4M | 102.1M | -3.3% |